Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated, commercial-stage biotechnology company, announced that it will host a conference call and webcast on Monday, Nov. 9, 2026, at 8:30 a.m. ET to report third-quarter 2026 financial results and operational highlights. Investors and interested parties can register to participate in the conference call or view the webcast through the company. A replay will be available under “IR Events” in the Investors section of the Tonix website.
To view the full press release, visit https://nnw.fm/va44Q
NOTE TO INVESTORS: The latest news and updates relating to TNXP are available in the company’s newsroom at https://nnw.fm/TNXP
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer